Wei Tu Selected Research

Janus Kinase Inhibitors

1/2022

The efficacy and safety of Janus kinase inhibitors in patients with atopic dermatitis: A systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei Tu Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 06/2005
9	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2012
6	Inflammation (Inflammations) 01/2022 - 01/2019
6	Hepatocellular Carcinoma (Hepatoma) 05/2015 - 01/2013
5	Asthma (Bronchial Asthma) 01/2021 - 01/2019
5	Infections 02/2016 - 03/2009
4	Carcinogenesis 09/2021 - 05/2015
4	Respiratory Hypersensitivity 01/2021 - 01/2019
4	Hemolytic-Uremic Syndrome 02/2016 - 03/2009
3	Glioma (Gliomas) 09/2021 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 07/2002
2	Autoimmune oophoritis 01/2022 - 06/2011
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2022
2	Reperfusion Injury 01/2021 - 01/2018
2	Lymphatic Metastasis 01/2021 - 06/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2014
2	COVID-19 01/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 11/2019
2	Liver Neoplasms (Liver Cancer) 11/2019 - 01/2014
2	Brain Neoplasms (Brain Tumor) 12/2017 - 01/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016 - 01/2012
2	Communicable Diseases (Infectious Diseases) 12/2015 - 12/2013
2	Botulism 11/2010 - 09/2008
1	Multiple Myeloma 03/2022
1	Addison Disease (Addison's Disease) 01/2022
1	Primary Ovarian Insufficiency 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Myocardial Infarction 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Flatulence 10/2020
1	Airway Remodeling 05/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2009
5	AllergensIBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	AntigensIBA 01/2022 - 06/2011
4	CytokinesIBA 01/2021 - 07/2002
4	VaccinesIBA 04/2019 - 05/2010
3	Environmental Pollutants (Pollutants, Environmental)IBA 09/2021 - 07/2016
3	CadmiumIBA 09/2021 - 05/2015
3	Circular RNAIBA 09/2021 - 01/2021
3	InflammasomesIBA 01/2021 - 11/2019
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
3	SirtuinsIBA 01/2019 - 05/2015
2	AutoantigensIBA 01/2022 - 06/2011
2	EnzymesIBA 01/2022 - 01/2020
2	Sirtuin 1IBA 01/2021 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 07/2002
2	C-Reactive ProteinIBA 01/2021 - 03/2015
2	Dermatophagoides farinae antigen f 1IBA 01/2021 - 01/2019
2	Benzo(a)pyreneIBA 01/2021 - 01/2019
2	Biological ProductsIBA 05/2020 - 12/2017
2	LigandsIBA 01/2020 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2020 - 07/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 06/2005
2	Proteoglycans (Proteoglycan)IBA 04/2019 - 10/2015
2	MethyltransferasesIBA 12/2017 - 01/2017
2	ChromatinIBA 11/2016 - 08/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2015 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2013
2	Netrin-1IBA 01/2015 - 06/2014
2	Shiga Toxins (Vero Toxin)IBA 01/2011 - 12/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2003 - 07/2002
1	Proteasome InhibitorsIBA 03/2022
1	Immunologic Factors (Immunomodulators)IBA 03/2022
1	Monoclonal AntibodiesIBA 03/2022
1	idecabtagene vicleucelIBA 03/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	SteroidsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	CateninsIBA 09/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2021
1	NADP (NADPH)IBA 01/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2021
1	PeroxiredoxinsIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	ProcalcitoninIBA 01/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021
1	NF-E2-Related Factor 2IBA 01/2021
1	MucinsIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Troponin IIBA 01/2021
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	NucleosidesIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2020
1	GTP Phosphohydrolases (GTPases)IBA 05/2020
1	rho-Associated KinasesIBA 05/2020

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2002
2	Thymectomy 01/2022 - 06/2011
1	Stem Cell Transplantation 03/2022
1	Polypharmacy 01/2021